Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article

• Published in: Journal of neurosurgery. Spine Vol. 18; no. 2; p. 112
• Main Authors: Burkus, J Kenneth, Dryer, Randall F, Peloza, John H
• Format: Journal Article
• Language: English
• Published: United States 01.02.2013
• Subjects: Adult; Aged; Bone Morphogenetic Protein 2 - adverse effects; Bone Morphogenetic Protein 2 - therapeutic use; Ejaculation; Humans; Intervertebral Disc Degeneration - surgery; Lumbar Vertebrae - surgery; Male; Middle Aged; Prospective Studies; Prostheses and Implants; Recombinant Proteins - adverse effects; Recombinant Proteins - therapeutic use; Risk Factors; Sexual Dysfunction, Physiological - etiology; Spinal Fusion - adverse effects; Spinal Fusion - instrumentation; Spinal Fusion - methods; Spondylolisthesis - surgery; Transforming Growth Factor beta - adverse effects; Transforming Growth Factor beta - therapeutic use; Treatment Outcome

The aim of this study was to determine the incidence and assess specific risk factors in the postoperative development of retrograde ejaculation (RE) in men treated for degenerative lumbar disc disease at the L4-5 or L5-S1 level with stand-alone anterior interbody implants with or without recombinan...